Pricing
  1. JP-listed companies
  2. AFC-HD AMS Life Science Co.,Ltd.
  3. Financials
  4. Operating income

AFC-HD AMS Life Science Co.,Ltd.【JP:2927】

Market cap
¥12.7B
P/E ratio
8.5x
AFC-HD Amus Life Science develops and sells health foods, cosmetics, and pharmaceuticals to consumers and medical institutions across multiple channels.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndOperating income (Million JPY)YoY (%)
Aug 31, 20252,410+25.75%
Aug 31, 20241,916+17.11%
Aug 31, 20231,636+61.82%
Aug 31, 20221,011-54.96%
Aug 31, 20212,245+105.29%
Aug 31, 20201,094+11.46%
Aug 31, 2019981-4.12%
Aug 31, 20181,023-4.28%
Aug 31, 20171,069+20.03%
Aug 31, 2016891-6.35%
Aug 31, 2015951+68.49%
Aug 31, 2014565

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)